Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Asbury Automotive
ABG
$3.85B
| $3.61M | ﹤0.01% |
20,128
+9,497
| +89% | +$1.59M |
|
|
NOVA
1827
CALL
DELISTED
Sunnova Energy
NOVA
| $3.6M | ﹤0.01% |
+200,000
| New | +$4.03M |
|
|
LHCG
1828
DELISTED
LHC Group LLC
LHCG
| $3.6M | ﹤0.01% |
22,271
+8,915
| +67% | +$1.47M |
|
1829
Agios Pharmaceuticals
AGIO
$1.93B
| $3.6M | ﹤0.01% |
128,210
+32,710
| +34% | +$922K |
|
1830
Universal Display
OLED
$4.19B
| $3.6M | ﹤0.01% |
33,303
+16,391
| +97% | +$1.72M |
|
1831
Belden
BDC
$5.19B
| $3.59M | ﹤0.01% |
49,911
+12,039
| +32% | +$874K |
|
1832
AerCap
AER
$23.8B
| $3.59M | ﹤0.01% |
61,482
-9,610
| -14% | -$531K |
|
1833
Ryman Hospitality Properties
RHP
$7.63B
| $3.58M | ﹤0.01% |
43,798
+21,521
| +97% | +$1.84M |
|
1834
LGI Homes
LGIH
$1.4B
| $3.58M | ﹤0.01% |
38,612
+6,735
| +21% | +$615K |
|
1835
Sanmina
SANM
$10.9B
| $3.57M | ﹤0.01% |
62,398
-225
| -0.4% | -$13.3K |
|
1836
Reinsurance Group of America
RGA
$16.1B
| $3.57M | ﹤0.01% |
25,139
-3,479
| -12% | -$486K |
|
|
CFFS
1837
DELISTED
CF Acquisition Corp. VII Class A Common Stock
CFFS
| $3.57M | ﹤0.01% |
350,000
| – | – |
|
1838
Wendy's
WEN
$1.46B
| $3.57M | ﹤0.01% |
157,728
-29,026
| -16% | -$620K |
|
|
SAVE
1839
DELISTED
Spirit Airlines, Inc.
SAVE
| $3.57M | ﹤0.01% |
183,118
+63,856
| +54% | +$1.31M |
|
1840
Saia
SAIA
$9.72B
| $3.56M | ﹤0.01% |
16,982
-40,025
| -70% | -$8.72M |
|
1841
Karyopharm Therapeutics
KPTI
$48M
| $3.56M | ﹤0.01% |
69,781
+39,417
| +130% | +$2.73M |
|
|
BKDT
1842
DELISTED
Brookdale Senior Living Inc. 7.00% Tangible Equity Units
BKDT
| $3.56M | ﹤0.01% |
+80,417
| New | +$3.78M |
|
|
TRIS
1843
DELISTED
Tristar Acquisition I Corp.
TRIS
| $3.54M | ﹤0.01% |
350,000
| – | – |
|
1844
PUT
PVH
PVH
$4.04B
| $3.54M | ﹤0.01% |
+50,100
| New | +$2.99M |
|
1845
Lyft
LYFT
$6.63B
| $3.53M | ﹤0.01% |
320,068
-403,180
| -56% | -$4.86M |
|
1846
Rocket Pharmaceuticals
RCKT
$394M
| $3.53M | ﹤0.01% |
180,225
+30,392
| +20% | +$560K |
|
1847
Lamar Advertising Co
LAMR
$16.3B
| $3.53M | ﹤0.01% |
37,356
+2,248
| +6% | +$208K |
|
|
AQNU
1848
DELISTED
Algonquin Power & Utilities Corp Units
AQNU
| $3.52M | ﹤0.01% |
147,565
+984
| +0.7% | +$30.6K |
|
1849
AGCO
AGCO
$7.2B
| $3.52M | ﹤0.01% |
25,346
-4,032
| -14% | -$497K |
|
1850
Murphy Oil
MUR
$4.78B
| $3.51M | ﹤0.01% |
81,563
+37,599
| +86% | +$1.69M |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 797 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 797 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.